Versant Capital Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.8K Sell
753
-95
-11% -$5.16K ﹤0.01% 1452
2026
Q1
$49.3K Buy
848
+414
+95% +$22.5K ﹤0.01% 1255
2025
Q4
$20K Buy
434
+7
+2% +$313 ﹤0.01% 1638
2025
Q3
$15.4K Sell
427
-1,587
-79% -$52.6K ﹤0.01% 1723
2025
Q2
$65.5K Buy
2,014
+1,851
+1,136% +$60.7K 0.01% 846
2025
Q1
$6.16K Buy
163
+71
+77% +$5.68K ﹤0.01% 1948
2024
Q4
$7.53K Buy
92
+74
+411% +$7.35K ﹤0.01% 1546
2024
Q3
$2.06K Buy
+18
New +$1.62K ﹤0.01% 1555
2023
Q3
Sell
-9
Closed -$449 2022
2023
Q2
$449 Buy
+9
New +$427 ﹤0.01% 1860

Other funds holding PCVX